Guohui Wan Selected Research

Circulating Neoplastic Cells

1/2021

Measurement of Circulating Tumor Cells to Track Hepatocellular Carcinoma Progression After Liver Transplantation-Case Report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guohui Wan Research Topics

Disease

14	Neoplasms (Cancer) 05/2022 - 09/2010
4	Carcinogenesis 05/2022 - 09/2010
3	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 02/2014
3	Liver Neoplasms (Liver Cancer) 01/2021 - 01/2020
2	Neoplasm Metastasis (Metastasis) 05/2022 - 10/2018
2	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2020
2	Hypoxia (Hypoxemia) 01/2021 - 01/2020
2	Breast Neoplasms (Breast Cancer) 01/2019 - 09/2010
2	Ovarian Neoplasms (Ovarian Cancer) 11/2016 - 09/2014
1	Neuroinflammatory Diseases 11/2022
1	Parkinson Disease (Parkinson's Disease) 11/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2022
1	Anxiety Disorders (Anxiety Disorder) 04/2022
1	Circulating Neoplastic Cells 01/2021
1	Adenoma (Adenomas) 01/2021
1	Polyps 01/2021
1	DiGeorge Syndrome (Syndrome, DiGeorge) 09/2014
1	Genomic Instability 02/2014
1	Ataxia Telangiectasia (Louis Bar Syndrome) 10/2013

Drug/Important Bio-Agent (IBA)

4	RNA (Ribonucleic Acid)IBA 05/2022 - 01/2019
4	N-methyladenosineIBA 05/2022 - 10/2018
3	MicroRNAs (MicroRNA)IBA 01/2021 - 02/2014
3	Pharmaceutical PreparationsIBA 01/2020 - 09/2010
2	EnzymesIBA 01/2021 - 11/2016
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2021 - 09/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 09/2010
2	Long Noncoding RNAIBA 01/2020 - 10/2013
2	6-methyladenineIBA 01/2019 - 10/2018
2	Biological ProductsIBA 02/2014 - 09/2010
1	RotenoneIBA 11/2022
1	nootkatoneIBA 11/2022
1	Mitogen-Activated Protein Kinase 3IBA 11/2022
1	Therapeutic UsesIBA 10/2022
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 10/2022
1	Phosphodiesterase 4 InhibitorsIBA 10/2022
1	Imiquimod (Aldara)FDA LinkGeneric 10/2022
1	Ethanol (Ethyl Alcohol)IBA 04/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2021
1	Fructose-Bisphosphate Aldolase (Aldolase)IBA 01/2021
1	Alpha-Ketoglutarate-Dependent Dioxygenase FTOIBA 01/2021
1	Keratins (Keratin)IBA 01/2021
1	VimentinIBA 01/2021
1	Cyclic PeptidesIBA 10/2020
1	B7-H1 AntigenIBA 10/2020
1	Granzymes (Granzyme)IBA 10/2020
1	PerforinIBA 10/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Sorafenib (BAY 43-9006)FDA Link 01/2020
1	MethyltransferasesIBA 01/2020
1	Epidermal Growth Factor (EGF)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	NucleotidesIBA 01/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019
1	Ubiquitin-Specific ProteasesIBA 11/2016
1	Epithelial Cell Adhesion MoleculeIBA 04/2015
1	AmanitinsIBA 04/2015
1	Proteins (Proteins, Gene)FDA Link 09/2014
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2014
1	Phosphotransferases (Kinase)IBA 02/2014
1	Histones (Histone)IBA 10/2013
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 09/2010

Therapy/Procedure

6	Therapeutics 05/2022 - 04/2015
2	Immunotherapy 05/2022 - 11/2021
1	Topical Administration 10/2022
1	Liver Transplantation 01/2021
1	Drug Therapy (Chemotherapy) 02/2014